Eli Lilly and Company and Zydus Cadila Reportedly Might Terminate R&D Deal

Published: Jan 03, 2012

Indian pharmaceutical company, Zydus Cadila is planning to withdraw from its collaboration with Eli Lilly that involved joint drug discovery for cardiovascular diseases. Both the companies entered into the drug discovery alliance in March 2009. It is believed that Zydus Cadila and Eli Lilly are faced with issues concerning differences in strategy and rising costs of research.

Back to news